Nektar Therapeutics

+$0.87 (+8.03%) As of 2:48 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a research-based biopharmaceutical company that focuses on discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology.

CEO
Howard W. Robin
Employees
718
Headquarters
San Francisco, California
Founded
1990

NKTR Key Statistics

Market cap
2.16B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.53M
High today
$11.85
Low today
$11.26
Open price
$11.31
Volume
497.49K
52 Week high
$26.75
52 Week low
$10.78

NKTR Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure